Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP130655.RAlrN_a2W5ffRkBh_yvmL_4tBPi2VUUerTjBgtc3MHsdc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP130655.RAlrN_a2W5ffRkBh_yvmL_4tBPi2VUUerTjBgtc3MHsdc130_assertion type Assertion NP130655.RAlrN_a2W5ffRkBh_yvmL_4tBPi2VUUerTjBgtc3MHsdc130_head.
- NP130655.RAlrN_a2W5ffRkBh_yvmL_4tBPi2VUUerTjBgtc3MHsdc130_assertion description "[The NAT2 gene polymorphism was not associated with susceptibility to IBD in Chinese populations, but the NAT2 slow acetylator genotypes were significantly associated with SP dose-related adverse effects of SASP in the treatment of IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130655.RAlrN_a2W5ffRkBh_yvmL_4tBPi2VUUerTjBgtc3MHsdc130_provenance.
- NP130655.RAlrN_a2W5ffRkBh_yvmL_4tBPi2VUUerTjBgtc3MHsdc130_assertion evidence source_evidence_literature NP130655.RAlrN_a2W5ffRkBh_yvmL_4tBPi2VUUerTjBgtc3MHsdc130_provenance.
- NP130655.RAlrN_a2W5ffRkBh_yvmL_4tBPi2VUUerTjBgtc3MHsdc130_assertion SIO_000772 17377643 NP130655.RAlrN_a2W5ffRkBh_yvmL_4tBPi2VUUerTjBgtc3MHsdc130_provenance.
- NP130655.RAlrN_a2W5ffRkBh_yvmL_4tBPi2VUUerTjBgtc3MHsdc130_assertion wasDerivedFrom gad-20150221 NP130655.RAlrN_a2W5ffRkBh_yvmL_4tBPi2VUUerTjBgtc3MHsdc130_provenance.
- NP130655.RAlrN_a2W5ffRkBh_yvmL_4tBPi2VUUerTjBgtc3MHsdc130_assertion wasGeneratedBy ECO_0000203 NP130655.RAlrN_a2W5ffRkBh_yvmL_4tBPi2VUUerTjBgtc3MHsdc130_provenance.